ARTICLE

FindCenter AddIcon

Ketamine for Depression Still Too Expensive for Widespread Use

By Technology Networks — 2020

A paper authored by researchers from McLean Hospital has determined that esketamine, a nasal spray to treat severe depression, is currently too expensive for widespread use. The study compared the costs and benefits of esketamine, an antidepressant approved by the U.S. Food and Drug Administration (FDA) last year for use in treatment-resistant major depressive disorder.

Read on www.technologynetworks.com

FindCenter Post-Image

Ketamine Therapy Is Going Mainstream. Are We Ready?

The mind-altering drug has been shown to help people suffering from anxiety and depression. But how it helps, who it will serve, and who will profit are open questions.

Article
Emily Witt
2021
FindCenter AddIcon
FindCenter Post-Image

Ketamine Is Revealing a New Understanding of Depression and the Brain

Some experts view ketamine as a tool to unravel the biological causes of depression and, perhaps someday, cure it.

Article
Lauren Tanabe
FindCenter AddIcon
FindCenter Post-Image

Experimental Treatments Changed the Course of the AIDS Epidemic; We Need the Same Approach to Mental Illness Today | Commentary

Demand from patients seeking help for their mental illnesses has led to underground use in a way that parallels black markets in the AIDS pandemic. This underground use has been most perilous for people of color, who face greater stigma and legal risks due to the War on Drugs.

Article
Monnica Williams, Morgan Campbell
2021
FindCenter AddIcon
FindCenter Post-Image

Study Finds Ketamine Can Help Patients Manage Depression and PTSD

Through this treatment plan, the patient was able to “reconceptualize her trauma” and “was able to move through difficult memories and emotions rather than letting them consume her,” explained U of O associate professor, Monnica Williams.

Article
Hannah Sabourin
2021
FindCenter AddIcon
FindCenter Post-Image

Could the Embrace of Psychedelics Lead to a Mental-Health Revolution?

The last time I was on ketamine, I was hooked up to an IV following surgery. This time, the drug—in general medical use as an anesthetic since 1970—arrived on my doorstep courtesy of Mindbloom, a new telemedicine company specializing in ketamine-based psychedelic therapy.

Article
Maya Singer
2021
FindCenter AddIcon
FindCenter Post-Image

Can Ketamine Treat Depression? the Answer May Lie in a Mysterious Brain Cell

To treat depression, the neurons which control the hormones serotonin and dopamine in our brains seem to get all the attention.

Article
Sophie Putka
2021
FindCenter AddIcon
FindCenter Post-Image

Are Psychedelics the Answer to Depression and Addiction?

A new generation of research into psilocybin could change how we treat numerous mental health conditions.

Article
Johann Hari
2018
FindCenter AddIcon
FindCenter Post-Image

An Introduction to MDMA

Once considered the quintessential party drug, MDMA (also known as “ecstasy,” “X,” or “molly”) is now experiencing a surge of interest in a completely different area: psychedelic-assisted psychotherapy.

Article
FindCenter
2022
FindCenter AddIcon
FindCenter Post-Image

An Introduction to LSD

LSD, or lysergic acid diethylamide, is a synthetic drug with potent psychedelic properties. Commonly known as acid, it was originally derived from compounds found in ergot, a fungus that grows on rye.

Article
FindCenter
2022
FindCenter AddIcon
FindCenter Post-Image

A Brief History of Psychedelic Psychiatry

In the 1950s a group of pioneering psychiatrists showed that hallucinogenic drugs had therapeutic potential, but the research was halted as part of the backlash against the hippy counterculture.

Article
Mo Costandi
2014
FindCenter AddIcon

EXPLORE TOPIC

Clinical Depression